George E. Dukes

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

Michael Camilleri, Allison R. Northcutt, Steven Kong et al. · The Lancet · 2000 · 558 citations

Functional Gastrointestinal Disorder, Gastrointestinal Pharmacology, Medicine +4

A Randomized Controlled Clinical Trial of the Serotonin Type 3 Receptor Antagonist Alosetron in Women With Diarrhea-Predominant Irritable Bowel Syndrome

Michael Camilleri, William Y. Chey, Emeran A. Mayer et al. · Archives of Internal Medicine · 2001 · 304 citations

Prevalence, Risk Factors, Clinical Consequences, and Treatment of Enteral Feed Intolerance During Critical Illness

Usha Gungabissoon, Kimberley Hacquoil, Chanchal Bains et al. · Journal of Parenteral and Enteral Nutrition · 2014 · 285 citations

The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease

Robert E. Spiller, David J. Humes, Elizabeth A. Campbell et al. · Alimentary Pharmacology & Therapeutics · 2010 · 218 citations · Full text

Symptomatic Diverticular Disease, Psychological Co-morbidities, Somatic Symptom Scale +18

Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study

Vinod S. Hegade, Stuart Kendrick, Robert L. Dobbins et al. · The Lancet · 2017 · 203 citations · Full text

Hepatology, Biliary Tract, Pharmacology +9